OTC Markets OTCPK - Delayed Quote USD

Hemogenyx Pharmaceuticals Plc (HOPHF)

1.2400
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Cost of Revenue
1,682.2030
1,682.2030
2,196.8220
283.6470
267.0570
Gross Profit
-1,682.2030
-1,682.2030
-2,196.8220
-283.6470
-267.0570
Operating Expense
3,876.3450
3,876.3450
3,333.6650
2,546.9750
1,949.2400
Operating Income
-5,558.5480
-5,558.5480
-5,530.4870
-2,830.6220
-2,216.2970
Net Non Operating Interest Income Expense
-230.6470
-230.6470
10.5660
-2,577.4310
-29.8740
Pretax Income
-6,696.4930
-6,696.4930
-3,986.9820
-5,108.3100
-2,095.0230
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-6,690.6780
-6,690.6780
-3,979.3140
-5,099.2280
-2,082.2200
Diluted NI Available to Com Stockholders
-6,690.6780
-6,690.6780
-3,979.3140
-5,099.2280
-2,082.2200
Basic EPS
-0.01
--
-0.01
-0.01
-0.01
Diluted EPS
-0.01
--
-0.01
-0.01
-0.01
Basic Average Shares
1,129,136.7270
--
979,749.3210
773,952.1660
414,833.0930
Diluted Average Shares
1,129,136.7270
--
979,749.3210
773,952.1660
414,833.0930
Total Operating Income as Reported
-6,465.8460
-6,465.8460
-3,997.5480
-2,702.7540
-2,150.3860
Rent Expense Supplemental
0
--
--
--
--
Total Expenses
5,558.5480
5,558.5480
5,530.4870
2,830.6220
2,216.2970
Net Income from Continuing & Discontinued Operation
-6,690.6780
-6,690.6780
-3,979.3140
-5,099.2280
-2,082.2200
Normalized Income
-6,690.6780
-6,690.6780
-3,979.3140
-5,271.1030
-2,082.2200
Interest Income
85.3440
85.3440
10.5990
17.9580
3.3650
Interest Expense
315.9910
315.9910
0.0330
2,595.3890
33.2390
Net Interest Income
-230.6470
-230.6470
10.5660
-2,577.4310
-29.8740
EBIT
-6,380.5020
-6,380.5020
-3,986.9490
-2,512.9210
-2,061.7840
EBITDA
-5,734.8210
-5,734.8210
-3,422.8770
-2,386.5810
-1,955.0310
Reconciled Cost of Revenue
1,682.2030
1,682.2030
2,196.8220
283.6470
267.0570
Reconciled Depreciation
645.6810
645.6810
195.2460
126.3400
106.7530
Net Income from Continuing Operation Net Minority Interest
-6,690.6780
-6,690.6780
-3,979.3140
-5,099.2280
-2,082.2200
Total Unusual Items Excluding Goodwill
--
--
--
171.8750
0
Total Unusual Items
--
--
--
171.8750
0
Normalized EBITDA
-5,734.8210
-5,734.8210
-3,422.8770
-2,558.4560
-1,955.0310
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 1/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PBIGF Paradigm Biopharmaceuticals Limited
0.2150
0.00%
 
N04.SG Nucana PLC (ADRs)
0.0440
-45.34%
 
DUL.F Alnylam Pharmaceuticals, Inc.
228.20
-6.55%
 
226950.KQ OliX Pharmaceuticals, Inc
43,500.00
-8.32%
 
N04.MU Nucana PLC R
0.0415
-61.57%
 
N04.F NuCana plc
0.0520
-52.73%
 
IMVT Immunovant, Inc.
14.02
-1.96%
 
BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
 
CLLS Cellectis S.A.
1.5800
+3.95%
 
ITOS iTeos Therapeutics, Inc.
6.67
-0.52%